FDA Import Refusal 1FX-6465159-9/10002/1 — PharmaChem Technologies G.B. Ltd.
The FDA refused shipment 1FX-6465159-9/10002/1 from PharmaChem Technologies G.B. Ltd. (Bahamas) on Jul 22, 2026. The refused product falls under Drugs and Biologics — TAMOXIFEN CITRATE (ANTI-ESTROGEN). Cited charges: 118,3280 This firm has 2 other import refusals on record.
Refusal Details
- Date
- Jul 22, 2026
- Country
- Bahamas
- Product Category
- Drugs and Biologics
- Product Code
- 61UAA05 TAMOXIFEN CITRATE (ANTI-ESTROGEN)
- Charges
- 118,3280